HISTOPATHOLOGICAL FEATURES IN STAGE-I NONSEMINOTAMOUS TESTICULAR GERM-CELL TUMORS CORRELATED TO RELAPSE

被引:38
|
作者
JACOBSEN, GK
RORTH, M
OSTERLIND, K
VONDERMAASE, H
JACOBSEN, A
MADSEN, EL
PEDERSEN, M
SCHULTZ, H
机构
[1] FINSEN INST,DEPT ONCOL,HERLEV,DENMARK
[2] AARHUS KOMMUNE HOSP,DK-8000 AARHUS,DENMARK
[3] AALBORG HOSP,DK-9000 AALBORG,DENMARK
关键词
relapse; Stage I non-seminomatous testicular germ cell tumour; surveillance only;
D O I
10.1111/j.1699-0463.1990.tb01047.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
156 patients with stage I non-seminomatous testicular germ cell tumour entered a countrywide randomized study comparing the effect of postoperative irradiation of retroperitoneal lymph nodes with surveillance only. A total of 150 patients were included in this investigation of factors associated with increased risk of relapse. Thirty-four patients (23 per cent) had a relapse, i.e. 11/67 (16 per cent) in the former and 23/83 (28 per cent) in the latter group. Histopathological studies of the orchidectomy specimens were performed in order to identify features associated with relapse. Pure embryonal carcinoma and vascular involvement were significantly associated with increased risk of relapse. Thus, the relapse rate in the observation group in patients with pure embryonal carcinomas was 50 per cent (5/10) and 36 per cent (19/53) in all patients with tumours with vascular involvement.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 50 条
  • [1] PREDICTING RELAPSE IN STAGE-I NONSEMINOTAMOUS GERM-CELL TUMORS OF THE TESTIS
    DEWAR, JM
    SPAGNOLO, DV
    JAMROZIK, KD
    VANHAZEL, GA
    BYRNE, MJ
    [J]. LANCET, 1987, 1 (8530): : 454 - 454
  • [2] A DECISION ANALYTIC APPROACH TO THE MANAGEMENT OF CLINICAL STAGE-I NONSEMINOTAMOUS GERM-CELL TESTICULAR-TUMORS
    TOSELLI, CV
    FLEMING, C
    ALBALA, D
    SELIKOWITZ, SM
    [J]. MEDICAL DECISION MAKING, 1990, 10 (04) : 330 - 330
  • [3] SURVEILLANCE IN PATIENTS WITH STAGE-I TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS
    GEZ, E
    WYGODA, M
    NUSSBAUM, N
    FIGER, A
    GIL, RI
    INBAL, M
    [J]. CANCER INVESTIGATION, 1993, 11 (01) : 10 - 14
  • [4] ORCHIECTOMY ALONE IN STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
    GELDERMAN, WAH
    KOOPS, HS
    SLEIJFER, DT
    OOSTERHUIS, JW
    MARRINK, J
    DEBRUIJN, HWA
    OLDHOFF, J
    [J]. CANCER, 1987, 59 (03) : 578 - 580
  • [5] WAIT-AND-SEE POLICY IN CLINICAL STAGE-I NONSEMINOTAMOUS GERM-CELL TUMORS OF THE TESTIS
    KOOPS, HS
    SLEIJFER, DT
    OOSTERHUIS, JW
    MARRINK, J
    DEBRUIJN, HWA
    OLDHOFF, J
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1986, 12 (03): : 283 - 287
  • [6] DISEASE RELAPSE IN PATIENTS WITH STAGE-I NONSEMINOTAMOUS GERM-CELL TUMOR (NSGCT) OF THE TESTIS ON ACTIVE SURVEILLANCE
    THOMPSON, PI
    HARVEY, VJ
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (811) : 769 - 769
  • [7] PROGNOSTIC FACTORS IN STAGE-I NONSEMINOTAMOUS GERM-CELL TESTICULAR-TUMORS MANAGED BY ORCHIECTOMY AND SURVEILLANCE - IMPLICATIONS FOR ADJUVANT CHEMOTHERAPY
    HOSKIN, P
    DILLY, S
    EASTON, D
    HORWICH, A
    HENDRY, W
    PECKHAM, MJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) : 1031 - 1036
  • [8] SURVEILLANCE OF CLINICAL STAGE-I NONSEMINOMA GERM-CELL TESTICULAR-TUMORS
    COLLS, BM
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1989, 102 (868) : 258 - 258
  • [9] METHOTREXATE FOR RELAPSE OF METASTATIC NONSEMINOTAMOUS GERM-CELL TUMORS
    ATKINSON, CH
    HORWICH, A
    PECKHAM, MJ
    [J]. MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1987, 4 (01): : 33 - 37
  • [10] RESULTS OF THE SURVEILLANCE POLICY OF STAGE-I NONSEMINOMATOUS GERM-CELL TESTICULAR-TUMORS
    COLLS, BM
    HARVEY, VJ
    SKELTON, L
    THOMPSON, PI
    DADY, PJ
    FORGESON, GV
    PEREZ, DJ
    [J]. BRITISH JOURNAL OF UROLOGY, 1992, 70 (04): : 423 - 428